Sinovac says Covid-19 vaccine efficacy improves 20 percent if dosing interval upped by 7 days
A Covid-19 vaccine developed in China has been shown to be 20 percent more effective in a small clinical trial group when doses are given three weeks apart, a spokesperson for the manufacturer, Sinovac Biotech, said on Monday.
Read Full Article at RT.com